IMPACT Therapeutics, Inc. Class H(HK:7630)
HK$8.72+0.40 (+4.87%)
HK:7630
IMPACT Therapeutics, Inc. Class H Revenue
HK$8.72
At close:+0.40 (+4.87%)
Want to see HK:7630 full AI Analyst Report?
IMPACT Therapeutics, Inc. Class H (7630) Revenue
IMPACT Therapeutics, Inc. Class H Revenue
IMPACT Therapeutics, Inc. Class H had a revenue of 15.31M in the quarter ending Jun 30, 2026, with 736.69%. This bring the company's revenue in the last twelve months to 17.14M, Increased 224.49%. In the fiscal year ending Dec 31, 2025, IMPACT Therapeutics, Inc. Class H had annual revenue of 5.33M with 13.86% growth.
- Revenue (ttm)
- 17.14M
- Revenue Growth
- 394.93%
- P/S Ratio
- 461.93
- Revenue/Employee
- HKD 60,557
- Employees
- 88
- Market Cap
- HKD 2.46B
Revenue Chart
IMPACT Therapeutics, Inc. Class H Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.33M | 648.64K | 13.86% |
| Dec 31, 2024 | 4.68M | -28.59M | -85.93% |
| Dec 31, 2023 | 33.27M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

